Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

We recently compiled a list of the 10 Companies Jump on Better Earnings, Outlook. In this article, we are going to take a ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

AI stocks are red-hot today. Last night Alphabet (Nasdaq: GOOGL) reported earnings and its stock is down 8% today. That ...

Given that Tempus AI has AI in its name, as you'd expect, the business deploys AI to improve the accuracy of their results, while delivering more personalized data-driven insights. They argue that ...

However, growth projections for Tempus AI’s legacy business are slightly below market consensus. Given these mixed signals – strong core business growth but with some revenue softness and ...

Tempus AI is a technology company that aims to advance precision medicine by applying AI to healthcare. The company went public in 2024, but shares have traded lower since its public debut.